Asabys Partners Launches New Investment Fund to Propel Technological Transfer in Spain
In a significant move for the Spanish life sciences sector, Asabys Partners, a prominent firm specializing in life sciences investment, is set to launch a new investment fund with a target of up to 120 million euros. This initiative is primarily aimed at facilitating the technological transfer from universities and research centers, ultimately fostering the creation of innovative new companies. The fund’s establishment comes as part of the Deep Start call, a program promoted by the Centre for the Development of Industrial Technology and Innovation (CDTI) in collaboration with the European Investment Fund (EIF).
A New Strategic Vertical for Asabys
This new fund, named Asabys Innvierte Tech Transfer FCRE, marks a pivotal moment for Asabys Partners as it embarks on a new strategic vertical focused on harnessing the potential of outstanding Spanish scientific research. The firm already manages two other funds under its core strategy, including the Sabadell Asabys Health Innovation Investments II (vintage 2023), which has made ten participations and continues to actively seek new investment opportunities across Spain and Europe. Additionally, Asabys is involved in managing the Alta Life Sciences fund, following its integration into the firm in October 2025.
A Dedicated Team Driving Innovation
The management of the new fund will be spearheaded by a dedicated team of seven professionals, including three co-equal partners: Emilio Erazo-Fischer, Montserrat Vendrell, and a third partner. This team will be bolstered by the broader Asabys staff, which currently comprises 18 members and is expected to grow to 20 by summer. With nearly 400 million euros in assets under management and 23 participations, Asabys Partners has established a solid foundation since its inception in 2018, working closely with universities, hospitals, and research centers.
Bridging the Gap Between Science and Industry
Emilio Erazo-Fischer, who will be based in Madrid, emphasizes the fund’s objective: “to work very closely with scientists and research groups to help shape their projects.” His presence in Madrid not only facilitates geographic expansion for Asabys but also enhances their ability to identify and invest in promising companies throughout Spain. The fund aims to foster collaboration among various research centers that are working on specific topics independently, encouraging them to come together for greater impact.
Addressing Funding Gaps in Spanish Science
Clara Campàs, another partner at Asabys, highlights a critical issue in the Spanish scientific landscape: “In Spain, we have excellent science that historically has not received enough funding to transform into solutions that impact people’s health.” She underscores the fund’s mission to bridge this funding gap, stating, “With this fund, we want to contribute to closing this gap, collaborating closely with researchers and centers to turn this knowledge into successful companies and value for society.”
A Vision for the Future
Asabys Partners is not just launching a fund; it is setting the stage for a transformative era in the Spanish life sciences sector. By focusing on technological transfer and collaboration between research institutions and the private sector, Asabys aims to unlock the potential of scientific discoveries and translate them into real-world solutions. The firm’s commitment to fostering innovation and supporting researchers is poised to make a lasting impact on the health and well-being of society.
